Details for Patent: 12,004,992

Which drugs does patent 12,004,992 protect, and when does it expire?

Patent 12,004,992 protects LILETTA and is included in one NDA.

This patent has twenty-four patent family members in nineteen countries.

Recent additions to Drugs Protected by US Patent 12,004,992

These patents are from the daily update and have not yet been integrated into the regular database

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	Patent No.	Product	Substance	Delist Req.	Patent Expiration	Usecode	Patented / Exclusive Use
Medicines360	LILETTA	levonorgestrel	SYSTEM	206229	Feb 26, 2015	RX	Yes			Y

Drugs Protected by US Patent 12,004,992

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Medicines360	LILETTA	levonorgestrel	SYSTEM;INTRAUTERINE	206229-001	Feb 26, 2015		RX	Yes	Yes				Y

International Family Members for US Patent 12,004,992

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2012282832
Australia	2015221468
Brazil	112014000440